• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

HYDERABAD: Dr Reddy's Laboratories Ltd announced on Monday the nationwide launch of Viboliv (Metadoxine), a drug to help prevent liver damage, in 500mg tablet and 300mg injectable form.

In a press release here, the company said Metadoxine has a direct effect on alcohol metabolism, accelerates the transformation of alcohol into acetaldehyde and thereon its urinary excretion.

According to the company, the drug aids in preventing liver damage resulting from prolonged alcohol intake and helps in reversing fatty liver degeneration. This is the first brand of Dr Reddy's in the Rs 199-crore segment, the release said.

Dr Reddy's has licensed Viboliv from Eurodrug Laboratories of Belgium. This is the third licensed product to be introduced in calendar 2005.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
KMML to raise capacity to 60,000 t by June

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line